Figures & data
Figure 1. Flow diagram showing the study population identified in the PPRN. aInfants born <28 weeks GA are the primary focus of the analyses reported in this article. bGiven the restrictive treatment policy of infants born at ≤24 weeks GA in the Netherlands, the study cohort only included pregnancies from 24 weeks GA onwards. Abbreviations. GA, gestational age; PPRN, PHARMO Perinatal Research Network.
![Figure 1. Flow diagram showing the study population identified in the PPRN. aInfants born <28 weeks GA are the primary focus of the analyses reported in this article. bGiven the restrictive treatment policy of infants born at ≤24 weeks GA in the Netherlands, the study cohort only included pregnancies from 24 weeks GA onwards. Abbreviations. GA, gestational age; PPRN, PHARMO Perinatal Research Network.](/cms/asset/d3be3bc1-f8f7-4ff9-81df-c94920ef9f7e/ijme_a_1999664_f0001_b.jpg)
Table 1. Selected infant and maternal characteristics by morbidity status during birth hospitalization of infants in the PHARMO Perinatal Research Network born EP (<28 weeks GA) from 1999 to 2015.
Table 2. Adjusted model predicting long LOS of birth hospitalizationa among EP infants (<28 weeks GA) in the PHARMO Perinatal Research Network born from 1999 to 2015.
Figure 3. Frequency of hospital readmissions at 1- and 2-years CA after birth among EP (<28 weeks gestational age) infants in the PHARMO Perinatal Research Network. (a) Infants with a birth record from 1999 to 2015 by pulmonary morbidity cohort. aWithin the time periods of outcome assessment (note: cohort sizes can therefore be larger than those presented at birth). (b) Frequency of hospital readmissions at 1- and 2-years CA after birth among EP infants in the PHARMO Perinatal Research Network with a birth record from 1999 to 2005, 2006 to 2009, and 2010 to 2015. Abbreviations. BPD, bronchopulmonary dysplasia; CA, corrected age; CLD, chronic lung disease; EP, extremely preterm; IQR, interquartile range; LOS, length of stay; PY, person-year.
![Figure 3. Frequency of hospital readmissions at 1- and 2-years CA after birth among EP (<28 weeks gestational age) infants in the PHARMO Perinatal Research Network. (a) Infants with a birth record from 1999 to 2015 by pulmonary morbidity cohort. aWithin the time periods of outcome assessment (note: cohort sizes can therefore be larger than those presented at birth). (b) Frequency of hospital readmissions at 1- and 2-years CA after birth among EP infants in the PHARMO Perinatal Research Network with a birth record from 1999 to 2005, 2006 to 2009, and 2010 to 2015. Abbreviations. BPD, bronchopulmonary dysplasia; CA, corrected age; CLD, chronic lung disease; EP, extremely preterm; IQR, interquartile range; LOS, length of stay; PY, person-year.](/cms/asset/3f3fa758-f0b7-489f-a732-d0081ccb94b6/ijme_a_1999664_f0003_b.jpg)
Figure 4. Mean costs of birth hospitalization for EP infants (<28 weeks gestational age). (a) By pulmonary morbidity; (b) by birth period. Abbreviations. BPD, bronchopulmonary dysplasia; CLD, chronic lung disease; EP, extremely preterm; SD, standard deviation.
![Figure 4. Mean costs of birth hospitalization for EP infants (<28 weeks gestational age). (a) By pulmonary morbidity; (b) by birth period. Abbreviations. BPD, bronchopulmonary dysplasia; CLD, chronic lung disease; EP, extremely preterm; SD, standard deviation.](/cms/asset/795941ef-c39c-4dc2-9397-11c1ad3c6d3a/ijme_a_1999664_f0004_b.jpg)
Figure 5. Costs of health care resource utilization among EP infants (<28 weeks gestational age). (a) By pulmonary morbidity; (b) by birth period. Costs are for infants with data available on birth hospitalization. Abbreviations. BPD, bronchopulmonary dysplasia; CA, corrected age; CLD, chronic lung disease; EP, extremely preterm; PY, person-year.
![Figure 5. Costs of health care resource utilization among EP infants (<28 weeks gestational age). (a) By pulmonary morbidity; (b) by birth period. Costs are for infants with data available on birth hospitalization. Abbreviations. BPD, bronchopulmonary dysplasia; CA, corrected age; CLD, chronic lung disease; EP, extremely preterm; PY, person-year.](/cms/asset/8ac02dec-0619-43cc-89fd-35383474b2ed/ijme_a_1999664_f0005_b.jpg)